uniQure Corp - QURE Company Long-Term Debts

Graphic logo of uniQure Pharma (QURE)

This chart of uniQure N.V. (QURE) trading reflects long-term debt amounting to 0.56. The company maintains a stable R&D workforce while selectively recruiting specialized experts. As a leader in gene therapy, uniQure N.V. (QURE) brings together global geneticists to combat orphan diseases. Financial stability is supported by the sales of an innovative Hemophilia B treatment and partner licensing royalties.

uniQure (QURE) - Company Long-Term Debts from 07/04/2022 to 10/31/2026

uniQure Corp - analytical breakdowns and key metrics (QURE)

- market price and analyst price targets:
Stock Price uniqure.com|QURE - Consensus Target
- issuer market value details:
Market Capitalization uniQure|QURE - Total Company Value
- book value of equity indicators:
Equity per Share uniQure|QURE - Book Capitalization|Market Capitalization to Book Value uniqure.com|QURE - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Capital Ratio uniQure N.V.|QURE - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital uniQure Pharma|QURE - Company Debts|Debt to Net Assets Ratio uniQure|QURE - Company Long-Term Debts|Short-Term Debt uniQure|Intermediate Coverage Ratio uniqure.com
- earnings and valuation multiples indicators:
QURE - Company Net Income
Analysis of all company metrics:uniqure.com
Core merchandise of uniQure Corp

This indicator captures the total volume of confirmed obligations with a maturity of more than one year, allowing for an objective assessment of the issuer's debt load and financial stability. By analyzing the long-term debt levels of the company, an investor determines the ability of uniQure N.V. (QURE) to fund costly R&D processes and retain key vectorology specialists without the risk of a sudden loss of access to capital.

Who uniQure N.V. competes with

Company Long-Term Debts Tempus Labs TEM|QGEN: Company Long-Term Liabilities|IONS - Company Long-Term Debts|Repligen Corp. (RGEN) - Company Long-Term Debt|Company Long-Term Indebtedness RNA|CRSP (CRISPR Therapeutics AG) - Company Long-Term Debts|genedx.com (WGS) - Long-Term Debt Volume|Company Long-Term Debt Ultragenyx (RARE)|Beam Therapeutics Inc (BEAM) - Long-Term Indebtedness|Sarepta Therapeutics Inc - Company Long-Term Liabilities|Company Long-Term Debts Twist Bioscience Corp TWST|TXG - Company Long-Term Debt|Company Long-Term Loans and Borrowings NTLA (intelliatx.com)|STOK: Company Long-Term Debts|Long-Term Debt BioLife Solutions Inc (BLFS)|Company Long-Term Liabilities WVE|MAZE: Company Long-Term Loans and Borrowings|Company Long-Term Debt Sionna Therapeutics Inc (SION)|primemedicine.com - Company Long-Term Indebtedness|Taysha Gene Therapies, Inc. - Company Long-Term Liabilities|Long-Term Debt Volume MeiraGTx Holdings (MGTX)|RGNX: Company Long-Term Liabilities|SLDB: Company Long-Term Debt|OCGN (Ocugen, Inc.) - Company Long-Term Liabilities|PACB - Long-Term Debt Volume|Company Long-Term Debt Benitec Biopharma|DSGN - Long-Term Indebtedness|Company Long-Term Liabilities RCKT (Rocket Pharmaceuticals Inc)|Company Long-Term Debts 4D Molecular Corp (FDMT)|Company Long-Term Debt Lexeo Therapeutics, Inc. LXEO|Company Long-Term Loans and Borrowings KRRO|Editas Medicine - Company Long-Term Debts|Long-Term Debt Silence Therapeutics PLC|PRQR: Company Long-Term Debts|Company Long-Term Indebtedness CDXS|Company Long-Term Debt Sangamo Therapeutics|Company Long-Term Indebtedness NAUT (Nautilus Biotechnology Inc)|Company Long-Term Debts MGX|Company Long-Term Debts Precision BioSciences Inc. (DTIL)|Generation Bio - Company Long-Term Liabilities|Company Long-Term Debts Boundless Bio Inc BOLD|XCUR - Company Long-Term Debt|IMNN (Imunon, Inc.) - Company Long-Term Indebtedness|PHIO: Company Long-Term Debts|MBIO - Long-Term Debt Volume|Company Long-Term Debt TransCode Therapeutics Inc.|BNGO - Long-Term Indebtedness|Company Long-Term Liabilities APDN (Applied DNA Sciences)|Company Long-Term Debts bluebirdbio.com (BLUE)|Company Long-Term Debt ImmunoPrecise Antibodies Ltd. IPA|Company Long-Term Loans and Borrowings OMGA|Singular Genomics Systems Inc - Company Long-Term Debts|Long-Term Debt Regulus|SYRS (Syros Pharmaceuticals) - Company Long-Term Liabilities|telesisbio.com - Company Long-Term Loans and Borrowings|Company Long-Term Debt TRACON Pharmaceuticals, Inc.|Company Long-Term Indebtedness UBX (Unity Biotechnology Inc.)